A scientist working under high-containment at CSIRO s Australian Centre for Disease Preparedness in Geelong, Victoria. | Credit: CSIRO-Australia
BENGALURU: The ‘warm’ vaccine formulations developed by scientists at IISc and biotech firm Mynvax result in antibodies that neutralise all current SARS-CoV-2 variants of concern, an independent evaluation of the formulations done by CSIRO, Australia, the agency that had done animal tests for the Oxford-Covishield vaccine candidate last year has shown.
The findings have been published (on Thursday) in the peer-reviewed ACS Infectious Diseases journal and will pave the way for clinical development leading to human trials. The published study was led by Prof Raghavan Varadarajan from IISc and TOI first reported about the vaccine in November 2020.
IISc s warm Covid vaccine effective against all key variants: Study businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.